Abstract
Vitamin A and its derivatives (collectively referred to as retinoids) are required for many fundamental life processes, including vision, reproduction, metabolism, cellular differentiation, hematopoesis, bone development, and pattern formation during embryogenesis. There is also considerable evidence to suggest that natural and synthetic retinoids have therapeutical effects due to their antiproliferative and apoptosis-inducing effects in human diseases such as cancer. Therefore it is not surprising that a significant amount of research was dedicated to probe the molecular and cellular mechanisms of retinoid action during the past decade. One of the cellular mechanisms retinoids have been implicated in is the initiation and modulation of apoptosis in normal development and disease. This review provides a brief overview of the molecular basis of retinoid signaling, and focuses on the retinoid-regulation of apoptotic cell death and gene expression during normal development and in pathological conditions in vivo and in various tumor cell lines in vitro.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by M. Piacentini
Rights and permissions
About this article
Cite this article
Nagy, L., Thomazy, V., Heyman, R. et al. Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ 5, 11–19 (1998). https://doi.org/10.1038/sj.cdd.4400337
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400337
Keywords
This article is cited by
-
High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea
Respiratory Research (2016)
-
Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer
European Journal of Nuclear Medicine and Molecular Imaging (2011)
-
An overview of the first 50Â years of transglutaminase research
Amino Acids (2009)
-
Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide
Cancer Chemotherapy and Pharmacology (2008)
-
Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells
Oncogene (2007)